Alcon AG at JPMorgan Healthcare Conference Transcript
Good morning, everybody. Welcome to day 2 of the JPMorgan Conference. I'm David Adlington. I head up the European med tech and services research team in London for JP. It's my pleasure to introduce -- we've got David and Tim on stage. Over to you guys.
All right. Thanks. Let me start with just a little bit of introduction. If you're not familiar with Alcon, we are an eye care company. We do a little bit of everything in eye care.
We have the pleasurable purpose of dealing with what is, generally speaking, one of the most severe concerns of elderly folks after memory loss, vision losses, the number 1 concern of folks as they age. And we work on refractive error. We work on presbyopia, dry eye if it's in the eye or if it's a malady from the eye, we are working on it.
We have a very, very simple strategy, which is we focus on eye care, we're a specialist. And what we're trying to do as a comparative advantage is know more about the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
